Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine patient-controlled analgesia after pediatric cleft palate repair
ChiCTR1900027385Phase 4Recruiting
- Sponsor
- Xiamen Chang Gung Hospital
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine in cleft palate (2 arms), sponsored by Xiamen Chang Gung Hospital. Primary endpoints: Ramsay score and Restlessness score. Started Nov 2019; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
cleft palate
Beyond the preview
Go deeper on ChiCTR1900027385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027385.